Johanna Haapamäki

Fecal calprotectin concentration predicts outcome in inflammatory bowel disease after induction therapy with TNFα blocking agents

Pauliina Molander, Clas-Göran af Björkesten, Harri Mustonen et al. · Inflammatory Bowel Diseases · 2012 · 170 citations · Full text

The interaction between values and organizational identification in predicting suggestion‐making at work

Jukka Lipponen, Anat Bardi, Johanna Haapamäki · Journal of Occupational and Organizational Psychology · 2007 · 111 citations

Workplace Psychology, Organizational Characteristic, Innovative Behaviour +20

Does fecal calprotectin predict short-term relapse after stopping TNFα-blocking agents in inflammatory bowel disease patients in deep remission?

Pauliina Molander, Martti Färkkilâ, Ari Ristimäki et al. · Journal of Crohn s and Colitis · 2014 · 94 citations

Increased risk for coronary heart disease, asthma, and connective tissue diseases in inflammatory bowel disease

Johanna Haapamäki, Risto P. Roine, Ulla Turunen et al. · Journal of Crohn s and Colitis · 2010 · 92 citations · Full text

Fecal calprotectin and S100A12 have low utility in prediction of small bowel Crohn's disease detected by wireless capsule endoscopy

Taina Sipponen, Johanna Haapamäki, Erkki Savilahti et al. · Scandinavian Journal of Gastroenterology · 2012 · 90 citations